KNC Laboratories Co Ltd
TSE:6568
Intrinsic Value
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. [ Read More ]
The intrinsic value of one
KNC Laboratories Co Ltd
stock under the Base Case scenario is
2 367.51
JPY.
Compared to the current market price of 1 386 JPY,
KNC Laboratories Co Ltd
is
Undervalued by 41%.
KNC Laboratories Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
KNC Laboratories Co Ltd's market capitalization is 10.7B JPY.
KNC Laboratories Co Ltd stock price is 1 386 JPY.
KNC Laboratories Co Ltd stock price (1386 JPY) is 41% less than its Intrinsic Value (2 367.51 JPY).
KNC Laboratories Co Ltd stock price (1386 JPY) is 50% less than its DCF Value (2 744.95 JPY). Open DCF Valuation
KNC Laboratories Co Ltd stock price (1386 JPY) is 30% less than its Relative Value (1 990.08 JPY). Open Relative Valuation
KNC Laboratories Co Ltd has upside potential of 178% compared to the average analyst price target.
Open Wall St Estimates
KNC Laboratories Co Ltd has positive Net Income for the last twelve months.
KNC Laboratories Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 12%.
KNC Laboratories Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 13%.
KNC Laboratories Co Ltd's Revenue has grown by 16% over the past 12 months.
KNC Laboratories Co Ltd has positive three-year average ROE (Return on Equity): 8%. The company is efficient at transforming stockholders' equity into net income.
KNC Laboratories Co Ltd has positive three-year average ROIC (Return on Invested Capital): 8%. The company is efficient at using invested capital to generate operating income.
KNC Laboratories Co Ltd has positive Free Cash Flow for the last twelve months.
KNC Laboratories Co Ltd has positive Operating Income for the last twelve months.
KNC Laboratories Co Ltd's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
KNC Laboratories Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 4% to 12%.
KNC Laboratories Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 4% to 13%.
KNC Laboratories Co Ltd's Revenue has been growing by 13% per year for the last 3 years.
KNC Laboratories Co Ltd has positive Gross Profit for the last twelve months.
KNC Laboratories Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (3B JPY) than debt (1B JPY).
KNC Laboratories Co Ltd's Altman Z-Score is very high and is equal to 3.46.
KNC Laboratories Co Ltd's short-term assets (7B JPY) exceed its short-term liabilties (2B JPY).
KNC Laboratories Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.12.
KNC Laboratories Co Ltd's long-term assets (16B JPY) exceed its long-term liabilties (4B JPY).
KNC Laboratories Co Ltd earns more than enough operating income (2B JPY) to safely cover interest payments on its debt (8m JPY).
Valuation Backtest
KNC Laboratories Co Ltd
Run backtest to discover the historical profit from buying and selling
KNC Laboratories Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
KNC Laboratories Co Ltd
Balance Sheet Decomposition
KNC Laboratories Co Ltd
| Current Assets | 7.3B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 972.9m |
| Other Current Assets | 3.7B |
| Non-Current Assets | 9.1B |
| PP&E | 7.6B |
| Intangibles | 49.8m |
| Other Non-Current Assets | 1.4B |
| Current Liabilities | 2.3B |
| Accounts Payable | 305m |
| Accrued Liabilities | 129.6m |
| Other Current Liabilities | 1.9B |
| Non-Current Liabilities | 1.9B |
| Long-Term Debt | 1.4B |
| Other Non-Current Liabilities | 418.8m |
Earnings Waterfall
KNC Laboratories Co Ltd
|
Revenue
|
9B
JPY
|
|
Cost of Revenue
|
-5.7B
JPY
|
|
Gross Profit
|
3.4B
JPY
|
|
Operating Expenses
|
-1.2B
JPY
|
|
Operating Income
|
2.1B
JPY
|
|
Other Expenses
|
-623.8m
JPY
|
|
Net Income
|
1.5B
JPY
|
Free Cash Flow Analysis
KNC Laboratories Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
KNC Laboratories Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
KNC Laboratories Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
KNC Laboratories Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
KNC Laboratories Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
KNC Laboratories Co Ltd
According to Wall Street analysts, the average 1-year price target for
KNC Laboratories Co Ltd
is 3 850 JPY
.
Shareholder Return
Price
KNC Laboratories Co Ltd
| Average Annual Return | -5.08% |
| Standard Deviation of Annual Returns | 20.02% |
| Max Drawdown | -40% |
| Market Capitalization | 10.7B JPY |
| Shares Outstanding | 7 719 258 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
KNC Laboratories Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. The company is headquartered in Kobe, Hyogo-Ken and currently employs 282 full-time employees. The company went IPO on 2018-03-15. The firm supplies necessary samples and products for research, development and production activities for product development, manufacture and sale, and also examines the manufacturing method. Organic chemical products are chemical products and intermediates used in the field of medicine and information electronics. Products include display materials, chemicals for semiconductor manufacturing, herbicides, fungicides, drug substances and intermediates, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
KNC Laboratories Co Ltd
stock under the Base Case scenario is
2 367.51
JPY.
Compared to the current market price of 1 386 JPY,
KNC Laboratories Co Ltd
is
Undervalued by 41%.
You don't have any saved screeners yet
